- Home
- CAG vs HALO Comparison
CAG vs HALO Comparison
Compare CAG & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAG
- HALO
- Stock Information
- Founded
- CAG 1919
- HALO 1998
- Country
- CAG United States
- HALO United States
- Employees
- CAG N/A
- HALO N/A
- Industry
- CAG Packaged Foods
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CAG Consumer Staples
- HALO Health Care
- Exchange
- CAG Nasdaq
- HALO Nasdaq
- Market Cap
- CAG 9.3B
- HALO 7.6B
- IPO Year
- CAG N/A
- HALO N/A
- Fundamental
- Price
- CAG $19.18
- HALO $76.90
- Analyst Decision
- CAG Hold
- HALO Buy
- Analyst Count
- CAG 11
- HALO 8
- Target Price
- CAG $21.73
- HALO $70.25
- AVG Volume (30 Days)
- CAG 11.3M
- HALO 2.0M
- Earning Date
- CAG 10-01-2025
- HALO 10-30-2025
- Dividend Yield
- CAG 7.30%
- HALO N/A
- EPS Growth
- CAG 233.33
- HALO 68.93
- EPS
- CAG 2.40
- HALO 4.37
- Revenue
- CAG $11,612,800,000.00
- HALO $1,178,672,000.00
- Revenue This Year
- CAG N/A
- HALO $32.57
- Revenue Next Year
- CAG N/A
- HALO $23.25
- P/E Ratio
- CAG $7.99
- HALO $17.65
- Revenue Growth
- CAG N/A
- HALO 34.97
- 52 Week Low
- CAG $18.19
- HALO $42.01
- 52 Week High
- CAG $33.04
- HALO $77.60
- Technical
- Relative Strength Index (RSI)
- CAG 48.50
- HALO 77.94
- Support Level
- CAG $19.03
- HALO $74.52
- Resistance Level
- CAG $19.59
- HALO $76.28
- Average True Range (ATR)
- CAG 0.43
- HALO 1.63
- MACD
- CAG 0.05
- HALO -0.06
- Stochastic Oscillator
- CAG 57.52
- HALO 88.60
About CAG ConAgra Brands Inc.
Conagra Brands is a packaged food company that operates predominantly in the United States (91% of fiscal 2025 revenue). Most of its revenue comes from frozen food, including brands like Marie Callender's, Healthy Choice, Banquet, and Birds Eye. Conagra also sells snacks, shelf-stable staples, and refrigerated food through brands like Duncan Hines, Hunt's, Slim Jim, Vlasic, Orville Redenbacher's, Reddi-wip, Wish-Bone, and Chef Boyardee. The company primarily sells through the US retail channel, with just 9% of fiscal 2025 revenue coming from international markets and 9% from foodservice.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.